A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors

Clinical trial NCT01478685 · COMPLETED

Trial details

NCT number: NCT01478685
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Urinary Bladder Neoplasms Carcinoma, Transitional Cell Ovarian Neoplasms Fallopian Tube Neoplasms Peritoneal Neoplasms Carcinoma, Non-Small-Cell Lung Carcinoma, Pancreatic Ductal Tumor Virus Infections

Start date: 2011-11-29
Primary completion: 2015-11-17
Enrollment: 169

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.